Skip to main content

Community

Technology Showcase Team Blends New and Old Approaches for 2024 Event

After eight years, the annual Technology Showcase isn’t showing any signs of slowing. In fact, according to members of the planning committee, there are still abundant opportunities to do more. The 2024 Tech Showcase, the eighth annual, will be held at FNL’s Advanced Technology Research Facility on September 4.

Where Fortitude Meets Hope: WHK Program Remains a Source of Inspiration for All

NCI Frederick recently bid farewell to its 33rd class of Werner H. Kirsten student interns. Having completed their senior year of high school—and a rigorous year-long internship—the students are off to confront their next big challenge. The campus recognized them all in the program’s first in-person closing ceremony since 2019.

Annual Spring Research Festival Gains Momentum, Shoots for More

Steak is always good, but it’s better with some sizzle. So said Kedar Narayan, Ph.D., in preparation for his keynote address at the 2024 Fort Detrick Spring Research Festival. Like a chef preparing a meal, he aimed for his lecture to offer the audience something particularly enticing.

NCI-60 HTS384: NCI Cancer Therapeutic Screen Enters New, High-throughput Era

Robot R, part of NCI Frederick’s new automated apparatus for screening potential cancer therapeutics, uses its arm to meticulously fill the wells of a 384-well plate with droplets of human tumor cell cultures smaller than a raindrop. Robot L stands at the ready on the other side of the apparatus, awaiting its own instructions. Laboratory staff members work nearby, but after they load the apparatus with the supplies it needs, the robotic system carries on independently.

Clinical Monitoring Research Program to Support Clinical Study Exploring Alternative to Cervical Cancer Screening

A new U.S. clinical trial will evaluate whether an at-home, self-collection technique to screen for cervical cancer is as accurate and effective as a Pap smear test done in a healthcare clinic. The Clinical Monitoring Research Program Directorate (CMRPD) at the Frederick National Laboratory for Cancer Research will coordinate the National Cancer Institute (NCI) study to be conducted at 25 sites.